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OBJECTIVES: Tension cost, the ratio of myosin ATPase activity to tension, reflects the economy of tension
development in the myocardium. To evaluate the mechanical advantage represented by the tension cost, we
studied papillary muscle contractility and the activity of myosin ATPase in the left ventricles in normal and
pathophysiological conditions.
METHODS: Experimental protocols were performed using rat left ventricles from: (1) streptozotocin-induced
diabetic and control Wistar rats; (2) N-nitro-L-arginine methyl ester (L-NAME) hypertensive and untreated Wistar
rats; (3) deoxycorticosterone acetate (DOCA) salt-treated, nephrectomized and salt- and DOCA-treated rats; (4)
spontaneous hypertensive rats (SHR) and Wistar Kyoto (WKY) rats; (5) rats with myocardial infarction and sham-
operated rats. The isometric force, tetanic tension, and the activity of myosin ATPase were measured.
RESULTS: The results obtained from infarcted, diabetic, and deoxycorticosterone acetate-salt-treated rats showed
reductions in twitch and tetanic tension compared to the control and sham-operated groups. Twitch and tetanic
tension increased in the N-nitro-L-arginine methyl ester-treated rats compared with the Wistar rats. Myosin ATPase
activity was depressed in the infarcted, diabetic, and deoxycorticosterone acetate salt-treated rats compared with
control and sham-operated rats and was increased in N-nitro-L-arginine methyl ester-treated rats. These parameters
did not differ between SHR and WKY rats. In the studied conditions (e.g., post-myocardial infarction,
deoxycorticosterone acetate salt-induced hypertension, chronic N-nitro-L-arginine methyl ester treatment, and
streptozotocin-induced diabetes), a positive correlation between force or plateau tetanic tension and myosin
ATPase activity was observed.
CONCLUSION: Our results suggest that the myocardium adapts to force generation by increasing or reducing the
tension cost to maintain myocardial contractility with a better mechanical advantage.
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INTRODUCTION
Myocardial contraction results from a cyclic interaction
between actin and myosin. In the heart, this mechanism
adapts to several pathophysiological conditions, including
pressure and volume overload, myocardial infarction, and
diabetes, to maintain adequate cardiac output. Although a
significant amount of data support a positive correlation
between mechanical parameters, muscle-shortening velocity
or force generation, and myosin ATPase activity (1-8),
controversies still exist.
Mechanical activity in different situations, such as
myocardial infarction, diabetes, or hypertension with and
without hypertrophy, might present different correlations
among the variables of force, the myosin isoforms involved
and myosin ATPase activity. This indicates that several
adaptive mechanisms might act to maintain myocardial
contractility under these conditions. Particular changes have
already been described for different physiopathological
conditions. For example, a previous report described that
after 12 weeks of myocardial infarction, papillary muscle
force and contraction kinetics were enhanced, but the level
of myosin ATPase activity was reduced (6). However,
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489results from Wang et al. (9) showed a correlation between
reduced contractility and a decrease in myosin ATPase
activity.
Myocardial hypertrophy has been reported to be asso-
ciated with reduced contraction speed, but changes in
myosin ATPase activity may or may not be present (4,10,11).
Diabetes is another condition that affects contractility by
reducing force magnitude, increasing contraction duration
(3,12,13), and producing a shift from myosin V1 to V3 (12).
In L-NAME-treated rats, the force of muscle contraction can
be increased without affecting the myosin isoform composi-
tion of the cardiac muscle (7,14). Moreover, force generation
can either increase or remain unchanged with myosin
isoform shifts and changes in the level of myosin ATPase
activity. These findings show the multiplicity of the
adaptive mechanisms involved in myocardial contractility
regulation, in both normal and pathophysiological condi-
tions.
To minimize the cause of the aforementioned controver-
sies, we used a previously suggested approach for the
analysis of tension cost:theratio of myosin ATPaseactivity to
tension (15-17). This ratio reflects the economy of tension
development and can be used to predict mechanical changes
corresponding to a biochemical change. Therefore, experi-
ments were performed in several models (e.g., myocardial
infarction, deoxycorticosterone acetate (DOCA)-salt-induced
hypertension, L-NAME-induced hypertension, experimental
diabetes) and in SHRs under stabilized conditions. The level
of myosin ATPase activity was correlated with the force
generation capacity and the tension cost for each condition.
MATERIALS AND METHODS
Male Wistar rats weighing 250 to 350 g, Wistar Kyoto
(WKY) rats weighing 230 to 350 g, and spontaneous
hypertensive rats (SHR) weighing 200 to 300 g were used
in this study. All experiments were conducted in compli-
ance with the guidelines for biomedical research as stated
by the Brazilian Societies of Experimental Biology. All rats
had free access to water and were fed rat chow ad libitum.
The rats were divided into 12 groups for the mechanical
and biochemical studies (Table 1). For the mechanical
studies, the groups included rats with myocardial infarction
(n=21) and sham-operated rats (n=23); diabetic rats (n=12)
and controls (n=12); DOCA-salt-treated (n=10), nephrec-
tomized rats (n=12), salt-treated (n=12) and DOCA-treated
rats (n=15); L-NAME-treated (n=7) and untreated (n=12)
rats; and SHR rats (n=22) and Wistar Kyoto rats (WKY,
n=10) as the controls (Table 1). For the biochemical studies,
other groups of rats were used, including infarction (n=7)
and sham-operated (n=7); diabetes (n=7) and control
(n=6); DOCA-salt-treated (n=6), salt-treated (n=6),
DOCA-treated (n=6) and nephrectomized (n=6); L-
NAME (n=9) and control (n=10); and SHR (n=8) and
WKY (n=8).
Diabetes induction
Diabetes was induced with streptozotocin (50 mg/kg
body weight diluted in 0.1 M citrate buffer solution, pH 4.5,
i.v. single injection). Two main groups of rats were used:
control rats and rats treated with streptozotocin for 30 days.
Blood glucose was measured using a hemoglucotest
(Advantage, Roche) before and after streptozotocin treat-
ment. Animals that did not develop hyperglycemia were
excluded. The blood pressure of each animal was measured
in vivo using a tail cuff (IITC Model 29 Pulse Amplifier, IITC
Inc., California).
L-NAME-induced hypertension
Rats were divided in two main groups. To induce
hypertension, one group was treated for 30 days with L-
NAME (N-nitro-L-arginine methyl ester). L-NAME (50 mg/
kg/day) was administered in the drinking water. Control
rats received untreated water. The day before the experi-
ments were conducted, the systolic blood pressure of the
rats was measured using a tail cuff (IITC Model 29 Pulse
Amplifier, IITC Inc., California).
DOCA-salt-induced hypertension
To induce hypertension with DOCA-salt, male 45-day-old
rats were uninephrectomized under halothane anesthesia,
as previously described (18). Four days later, the rats were
treated with either deoxycorticosterone acetate (DOCA,
8 mg/kg twice a week) or vehicle (soybean oil, 0.1 mL/
animal). This treatment was repeated twice per week for 30
days. The uninephrectomized rats received drinking water
as vehicle, and the DOCA-salt-treated rats received a saline
solution (0.9% NaCl) as their drinking water during the
treatment period. The day before the experiments were
conducted, the systolic blood pressure of all rats was
measured using a tail cuff (IITC Model 29 Pulse
Amplifier, IITC Inc., California). Animals that did not
develop hypertension were excluded.
Myocardial infarction model
Myocardial infarction was induced by ligation of the left
coronary artery as previously described (19). Anesthesia
was induced by halothane. After recovery, the rats were
kept in collective cages at the animal facility. To avoid stress
and because we had previous measurements of systolic
blood pressure in a similar group of rats, systolic blood
pressure was not measured in the tail.
Studies of myocardial contractility
The rats received 500 units of heparin i.p., and after
10 min, they were anesthetized with 45 mg/kg of sodium
pentobarbital i.p. The hearts were rapidly removed after
thoracotomy and perfused with Krebs solution through the
aortic stump to permit proper selection and dissection of the
left ventricle papillary muscles. The papillary muscles were
immersed in a 50-mL water-jacketed bath maintained at
29¡1˚C and gassed with (95% O2 and 5% CO2) Krebs
bicarbonate buffer solution. The muscles were stretched to
Lmax (muscle length at which active tension is maximal) and
Table 1 - Experimental and control groups. The number
of samples is indicated in parentheses.
Experimental groups Control groups
Myocardial infarction (21) Sham-operated (23)
Spontaneously hypertensive rats
(22)
Wistar Kyoto (10)
Diabetic (12) Wistar Control (12)
DOCA-Salt (10) Nephrectomized (12)
Salt-treated (12)
DOCA-treated (15)
L-NAME (7) Untreated Wistar (12)
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490stimulated with isolated rectangular pulses (10 to 15 V, 12-
ms duration) using a pair of platinum electrodes placed
along the entire length of the muscle. The standard
stimulation rate was 0.5 Hz (steady-state). Recording was
begun after 60 minutes to allow for the beating preparation
to adapt to the new environmental conditions.
The bathing solution was a modified Krebs solution with
the following composition (in mM): 120 NaCl, 5.4 KCl, 1.2
MgCl2 6H2O, 1.25 CaCl2 2H2O, 2.0 NaH2PO4H2O, 1.2
Na2SO4, 27 NaHCO3, and 11 glucose, gassed with 95% O2
and 5% CO2, pH 7.4.
The developed force (F) was measured with an isometric
force transducer (Nihon-Kohden, TB 612T, Tokyo), which
was recorded on a chart recorder (Nihon-Kohden, RM-6200,
Tokyo) and normalized to the muscle cross-sectional area
(g/mm
2). Considering the papillary muscle as a cylinder
and the tissue density as 1, the cross-sectional area was
calculated by dividing the muscle length at Lmax by its
weight. To avoid the possibility of a hypoxic core, we
performed the experiments at low temperatures (29¡1˚C)
as previously described (20).
The influence on the contractile machinery was studied in
another group of papillary muscles during tetanic stimula-
tion. Tetanic tension was obtained after treatment with
5 mM caffeine (for 20 minutes, at a rate of 10 Hz, for 15 s) as
previously described (20). The tetanic contractions devel-
oped a fast upstroke (tetanic peak force) followed by a slow
decay (tetanic plateau force). Tension was measured at the
peak and in the middle of the plateau. The muscles
remained under steady-state stimulation for at least
10 min between stimuli. This protocol was repeated twice.
Studies of myosin ATPase activity
To evaluate myosin ATPase activity, the left ventricle was
dissected and assayed as described previously (11). Briefly,
myosin was prepared from minced and homogenized left
ventricles, which were extracted briefly with KCl phosphate
buffer (0.3 M KCl and 0.2 M phosphate buffer, pH 6.5).
Myosin ATPase activity was assayed by measuring Pi
liberation from 1 mM ATP in the presence of 50 mM
HEPES, pH 7, 0.6 M KCl, and 5 mM CaCl2 or 10 mM
EGTA in a final volume of 200 ml. The level of myosin
activity was measured without Mg
2+ in the medium. There
is no significant Ca
2+-ATPase activity in the sarcoplasmic
reticulum membrane, which requires high Mg
2+ and low
Ca
2+ concentrations. Controls containing the enzyme pre-
paration and trichloroacetic acid were used to correct for
non-enzymatic hydrolysis of the substrate. All samples were
prepared in duplicate. The level of enzyme activity was
calculated as the difference between the levels observed in
the presence of Ca
2+ and in the presence of 10 mM EGTA.
The level of inorganic phosphate was determined according
to the method proposed by Chan et al. (21). Specific activity
is reported as nmol Pi released per min per mg of protein
unless otherwise stated. Protein was measured using the
Coomassie Blue method according to Bradford (22) using
bovine serum albumin as a standard.
Drugs used
Pentobarbital sodium was obtained from Cristalia
Produtos Quı ´micos Farmace ˆuticos Ltda. (Sa ˜o Paulo, SP,
Brazil). Heparin was obtained from Roche Q.F.S.A. (Rio de
Janeiro, RJ, Brazil) and Sigma. Bovine serum albumin,
Na2ATP, and anhydrous caffeine were purchased from
Sigma Chemical Co. (St. Louis, MO, U.S.A.). All of the other
reagents used were of analytical grade and from Sigma, E.
Merck (Darmstadt, Germany), or Reagen (Rio de Janeiro, RJ,
Brazil).
Statistical analysis
The results are presented as the means ¡ SEM with n
indicating the number of observations. The values were
analyzed using ANOVA (one- and two-way) and unpaired
Student t-tests. When ANOVA revealed a significant
difference, the Tukey test was applied. Linear regression
was used for correlation analysis. p,0.05 was considered to
be significant. Data analysis and figure preparation were
performed using GraphPad Prism
TM (version 2.0, GraphPad
Software, San Diego, CA, USA) and GB-STAT (version 4.0,
Dynamic Microsystem Inc., Silver Spring, MD).
RESULTS
Four weeks after myocardial infarction, the isometric
force development (Figure 1A) and peak and plateau tetanic
tension (Figure 2A, Table 3) were reduced. The level of
myosin ATPase activity was also reduced compared to that
observed in sham-operated rats (Figure 3A).
SHRs were hypertensive (systolic pressure; SHR=213¡
7.5 mmHg vs. WKY=124¡1.3 mmHg; p,0.01, unpaired
Student’s t-test) and showed left ventricular hypertrophy
(Table 2). Force development and peak and plateau tetanic
tension were similar between SHRs and WKY rats (Figure 1B
and 2B). For SHRs and WKY rats, this similarity in terms of
tetanic tension was paralleled by similar levels of myosin
ATPase activity (Figure 3B).
Thirty days after streptozotocin administration, the diabetic
group showed an increased blood glucose level (DB=488¡
20.5 mg/dL and Control=82¡1.8 mg/dL, p,0.01, unpaired
Student’s t-test) and a reduction in body weight (Table 2)
when compared to baseline (Control: 270¡3.16 vs Diabetic:
280¡3.63, p.0.05). The papillary muscles from diabetic rats
developed less isometric tension than those from controls
(Figure 1C); the same trend was observed for peak and
plateau tetanic tension (Figure 2C, Table 3). The level of
myosin ATPase activity was reduced (Figure 3C). In the
DOCA-salt group, only the DOCA salt-treated rats were
hypertensive. The other three subgroups (nephrectomized,
salt treated, and DOCA treated) were normotensive (DOCA
salt=201¡3.4 mmHg vs. Nefrec=119¡1.1 mmHg; Salt=
120¡2.1 mmHg and DOCA=135¡2.0 mmHg: p,0.01, one-
way randomized ANOVA). DOCA-salt rats also presented
reduced body weight compared to the other three subgroups
and displayed significant LV hypertrophy at the end of the
treatment (Table 2). Isometric tension (Figure 1D) and peak
and plateau tetanic tension (Figure 2D, Table 3) were reduced
in the DOCA-salt group compared with the other groups.
Myosin ATPase activity was also reduced in the DOCA-salt
group (Figure 3D).
We used L-NAME treatment for 30 days to create a model
with hypertension but without LV hypertrophy. Arterial
systolic pressure increased (Control=119¡0.8 mmHg and L-
NAME=196¡4.4 mmHg; p,0.01, unpaired Student t-test),
but no hypertrophy developed (Table 2). L-NAME-treated
rats developed increased isometric force (Figure 1E), but
peak and plateau tetanic tension presented no significant
differences (Figure 2E, Table 3). Myosin ATPase activity
increased in the L-NAME group (Figure 3E).
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reported controversies, we attempted to identify a correla-
tion between mechanical changes and biochemical changes.
According to Rundell et al. (17), the relationship between
myosin ATPase activity and developed force provides
information about the energetic cost of tension. As shown
in Figure 4, in which force is plotted against myosin ATPase
activity (tension cost) observed in the L-NAME, DOCA-salt,
diabetic, Wistar control, SHR and WKY groups, there was a
positive correlation among these variables under both
normal conditions (Figure 4A) and with the use of tetanic
plateau force (Figure 4B).
DISCUSSION
Our results demonstrate that tension cost, the ratio of
myosin ATPase activity to force, correlates mechanical and
corresponding biochemical changes. The ratio shows that
the contractile state of the myocardium in several condi-
tions, such as post-myocardial infarction, DOCA-salt-
induced hypertension, chronic L-NAME treatment, and
streptozotocin-induced diabetes, is represented by a posi-
tive correlation between tension developed and myosin
ATPase activity. This characterizes the energetic cost of
tension as an attempt to obtain a better mechanical
advantage.
The relationship between myosin ATPase activity and
contraction velocity is well established (1). In the rat
myocardium, however, the activity and expression of
myosin ATPase has been suggested to reflect myocardial
force development (2-7). The three myosin isoforms are
denoted as V1, V2, and V3. The V1 isoform (aa) possesses
the highest ATP hydrolysis velocity of the three and
composes the heavy chains. The isoform displaying the
lowest velocity is V3 (bb); V2 (ab) is a mixed isoform with
intermediate velocity (5,8,10). However, during adaptation
to several pathophysiological conditions, Ca
2+-handling
mechanisms might prevent mechanical deficiencies before
stable conditions are achieved. These various adaptive
mechanisms explain why correlations between force devel-
opment and the biochemical activity in cardiac muscle are
still a matter of debate. We then performed experiments
with several models that exhibit changes in myosin ATPase
activity and force when conditions stabilize.
Myocardial infarction is associated with adaptive changes
that enable the heart to maintain an effective systolic
performance (23). The infarcted chamber increases its
volume and the end-diastolic pressure to maintain cardiac
output. These changes are limited by the contractile capacity
of the remaining myocardium and the energetic cost of the
mechanical activity. Our results obtained 30 days after
myocardial infarction show a reduction in isometric and
tetanic tension. These findings and those regarding the area
of infarction are similar to previous results from our
laboratory (23-25). However, the mechanisms underlying
this force reduction remain to be determined. Min et al. (26)
Figure 1 - Effects of myocardial infarction (A), hypertension (B), diabetes (C), DOCA-salt-induced hypertension (D), and chronic L-NAME
treatment (E) on the isometric force (g/mm
2) in the rat papillary muscle. The results represent the mean ¡ SEM, and N indicates the
number of experiments. *p,0.05 vs. control, Sham, NF, Salt, and DOCA (t-test or one-way ANOVA, repeated measurements).
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Hyposensitivity to positive inotropic stimulation with
calcium and isoproterenol was also reported (19). These
findings are paralleled by the reduction in myosin ATPase
activity reported here. Other authors have reported similar
findings (27,28), although without the shift of V1 to V3 MHC
(28). Wang et al. (9) investigated the time course of myosin
ATPase activity after myocardial infarction and found that
the level of left ventricular myosin ATPase activity began to
decrease at four weeks. These different adaptive changes
might result from a phenomenon recently described in rats
such that 30-day myocardial infarctions with similar scar
areas can behave normally or, alternately, lead to the
development of heart failure (25).
SHRs develop hypertension and myocardial hypertrophy.
These rats have a large period of stable hypertrophy with
preserved or enhanced contractile function (23,29). In fact,
we did not find differences in force development in these
rats compared to WKY rats. Previous reports suggest an
increase in contractile force resulting from either increased
Ca
2+ entry through L-type Ca
2+ channels and release from
the sarcoplasmic reticulum (29) or enhanced contractility
without changes in the levels of contractile proteins but with
large calcium spikes (30). However, other reports described
reductions in force under steady-state or isoproterenol
stimulation (31) resulting from increased calcium uptake
by the sarcoplasmic reticulum and an increase in the level of
phospholamban phosphorylation. Taken together, these
results show that the development of force and the nature
of calcium handling change during the evolution of
hypertension in SHRs. Our results, however, showed no
differences in either the development of force or the level of
myosin ATPase activity, suggesting that we studied SHRs
with stable contractility function, which explains why the
SHRs displayed tension cost similar to that of WKY rats.
Regarding the development of tetanic tension, our results
demonstrate that under tetanic stimulation, the isometric
tension force was not modified in SHRs compared with
WKY rats. In accordance with these results, the level of
myosin ATPase activity in SHRs was similar to that in WKY
rats. Other reports show a reduction in myosin ATPase
activity but only after longer periods (32,33).
Diabetes is a chronic syndrome resulting from insulin
deficiency, which also affects the cardiovascular system.
Cardiac contractility dysfunction is described in streptozo-
tocin-induced diabetes in rats. Notably, our results are in
Figure 2 - Effects of myocardial infarction (A), hypertension (B), diabetes (C), DOCA-salt-induced hypertension (D), and chronic L-NAME
treatment (E) on the tetanic peak force (g/mm
2) in rat papillary muscle. The results represent the mean ¡ SEM, and N indicates the
number of experiments. *p,0.05 vs. control, Sham, NF, Salt, and DOCA (t-test or one-way ANOVA, repeated measurements).
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493Figure 3 - Effects of myocardial infarction (A), hypertension (B), diabetes (C), DOCA-salt-induced hypertension (D), and chronic L-NAME
treatment (E) on myosin ATPase activity (nmol/Pi/min/mg) in the rat left ventricle. The results represent the means ¡ SEM, and N
indicates the number of experiments. *p,0.05 vs. control (t-test or one-way ANOVA, repeated measurements).
Table 2 - Measurements of final body weight (g), left
ventricular weight (mg), and the left ventricular weight/
body weight (LVW/BW) ratio (mg/g) in myocardial
infarction (MI) and sham-operated (Sham) rats;
spontaneously hypertensive rats (SHR) and Wistar Kyoto
(WKY), diabetic; nephrectomized (Nefrec), salt-treated
(salt), DOCA-treated, DOCA-Salt (DOCA), and L-NAME-
treated rats.
Groups
Final Body
Weight (g)
Left Ventricular
Weight (mg)
LVW/BW ratio
(mg/g)
Sham (23)
MI (21)
347¡9.9
331¡7.9
660¡20
670¡40
1.90¡0.05
2.04¡0.13
WKY (10)
SHR (22)
296¡7.6
251¡7.8*
600¡20
700¡30*
2.05¡0.04
2.82¡0.09*
Control (12)
Diabetic (12)
289¡4.2
262¡3.9*
550¡20
552¡10
1.91¡0.06
1.99¡0.03
Nefrec (12)
Salt (12)
DOCA (15)
DOCA-Salt (10)
285¡6.5
288¡8.7
289¡8.0
249¡7.7*
540¡10
570¡20
600¡20
790¡30*
1.89¡0.04
1.96¡0.04
2.07¡0.03
3.19¡0.16*
Control (12)
L-NAME (7)
340¡7.8
319¡12.7
670¡20
660¡20
1.97¡0.05
2.08¡0.05
Values represent the means ¡ SEM. ANOVA one-way and t-test:
*p,0.05 vs. controls of the respective groups. The number of animals is
indicated in parentheses.
Table 3 - Changes in plateau tetanic tension (g/mm
2)a s
observed in papillary muscles obtained from myocardial
infarction (MI) and sham-operated (Sham) rats;
spontaneously hypertensive rats (SHR) and Wistar Kyoto
(WKY), diabetic; nephrectomized (Nefrec), salt-treated
(salt), DOCA-treated, DOCA-salt-treated (DOCA), and L-
NAME-treated rats.
Groups Plateau Tetanic Tension (g/mm
2)
Sham (23)
MI (21)
1.77¡0.22
0.80¡0.10*
WKY (10)
SHR (22)
0.87¡0.14*
0.97¡0.13*
Control (12)
Diabetic (12)
1.79¡0.30
0.92¡0.17*
Nefrec (12)
Salt (12)
DOCA (15)
DOCA-salt (10)
1.97¡0.14
2.08¡0.23
2.20¡0.25
1.06¡0.25*
Control (12)
L-NAME (7)
1.71¡0.18
2.30¡0.42
Values represent the means ¡ SEM. ANOVA one-way and t-test: *p,0.05
vs. controls of respective groups. The number of animals is indicated in
parentheses.
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494accordance with those showing isometric force reduction
reported by Fein et al. (12) and Dhalla et al. (3). Other
reports showed no alteration in force alterations (17,34) but
differ from our study because myocardial hypertrophy
was present in their preparations. Regarding evaluation of
the contractile proteins, our results show a reduction in
tetanic tension and a decrease in myosin ATPase activity.
These findings are in accordance with previous reports
(17,35).
The DOCA-salt rat exhibited cardiac hypertrophy after 30
days as previously reported (23). However, the reports
regarding changes in contractility are controversial (36,37).
Our findings show that DOCA-salt-treated papillary mus-
cles developed less tension, but other studies show no
change or even increased tension (36,37). However, all
related studies report cardiac hypertrophy. Tetanic tension
and myosin ATPase activity were also reduced, suggesting
the involvement of contractile proteins.
L-NAME treatment induces severe hypertension but little
or no hypertrophy. Our findings show no hypertrophy and
are in accordance with previous reports (7,14). Meanwhile,
other reports show hypertrophy (38) or hypotrophy (39).
The increased isometric force development observed in the
present study is in agreement with the results reported
by Bartunek et al. (14), which described an increase in
contractility indexes. However, we observed no changes in
tetanic tension development, although the level of myosin
ATPase activity was found to be increased.
Therefore, our results, in agreement with previous
reports, demonstrate that tension cost is the best way to
correlate mechanical and biochemical parameters (15-
17,39). We used this approach to maintain consistency,
and our results are in accordance with those reports.
Interestingly, as shown in Figure 4, once the sarcoplasmic
reticulum activity is reduced, the tension cost (myosin
ATPase activity vs. plateau tetanic tension) reveals a clear
correlation, suggesting that any existing discrepancies may
be due to the interference of sarcoplasmic reticulum
adaptation mechanisms.
Our results suggest that higher myosin ATPase activity
leads to a higher energy cost in association with the
development of tension. When myosin ATPase activity in
the heart is reduced, there is an accompanying reduction in
tension cost. Based on these findings, we suggest that the
myocardium increases or decreases tension cost to maintain
myocardial contractility with a better mechanical advantage.
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